Norweg Anna, Oh Cheongeun, DiMango Angela, Hofferber Brittany, Spinner Michael, Stavrolakes Kimberly, Pavol Marykay, Lindenauer Peter, Murphy Charles G, Simon Naomi M
Author Affiliations: Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, USA (Dr Norweg); Department of Rehabilitation and Regenerative Medicine, Columbia University Irving Medical Center, New York, New York, USA (Ms Hofferber and Mr Spinner); Department of Population Health, New York University Grossman School of Medicine, New York, New York, USA; Department of Physical Therapy, Outpatient Pulmonary Rehabilitation Program, New York Presbyterian Hospital, New York, New York, USA (Dr Stavrolakes); Department of Neurology and Rehabilitation and Regenerative Medicine, Columbia University Irving Medical Center, New York, New York, USA (Dr Pavol); Department of Healthcare Delivery and Population Sciences, University of Massachusetts Chan Medical School, Springfield, MA, USA (Dr Lindenauer); Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Irving Medical Center, New York, New York, USA (Drs DiMango and Murphy); and Department of Psychiatry, New York University Grossman School of Medicine, New York, New York, USA (Dr Simon).
J Cardiopulm Rehabil Prev. 2025 Mar 1;45(2):118-131. doi: 10.1097/HCR.0000000000000939. Epub 2025 Feb 13.
To evaluate the feasibility and acceptability of Capnography-Assisted Learned Monitored (CALM) Breathing, a carbon dioxide (CO 2 ) biofeedback, and motivational interviewing intervention, to treat dyspnea and anxiety together.
We randomized adults (n = 42) with chronic obstructive pulmonary disease (COPD) to a 4-week, 8-session intervention (CALM Breathing, n = 20) or usual care (n = 22). The CALM Breathing intervention consisted of tailored, slow nasal breathing exercises, capnography biofeedback, motivational interviewing, and a home breathing exercise program. The intervention targeted unlearning dysfunctional breathing behaviors. All participants were offered outpatient pulmonary rehabilitation (PR) in the second phase of the study. The primary outcomes were feasibility and acceptability of CALM Breathing. Exploratory secondary outcomes included respiratory and mood symptoms, physiological and exercise tolerance measures, quality of life, and PR uptake.
Attendance at CALM Breathing sessions was 84%, dropout was 5%, and home exercise completion was 90% and 73% based on paper and device logs, respectively. Satisfaction with CALM Breathing therapy was rated as "good" to "excellent" by 92% of participants. Significantly greater between-group improvements in secondary outcomes-respiratory symptoms, activity avoidance, oxygen saturation (SpO 2 ), end-tidal CO 2 , and breathing self-regulation (interoception)-were found post-intervention at 6 weeks in support of CALM Breathing compared with usual care. At 3 months (after PR initiation), statistically significant between-group differences in Borg dyspnea and SpO 2 post-6-minute walk test were identified also supporting CALM Breathing.
Patient-centered CALM Breathing was feasible and acceptable in adults with COPD and dyspnea anxiety. A CALM Breathing intervention may optimize dyspnea treatment and complement PR.
评估二氧化碳生物反馈及动机性访谈干预措施——二氧化碳描记辅助学习监测(CALM)呼吸法,用于同时治疗呼吸困难和焦虑症的可行性及可接受性。
我们将患有慢性阻塞性肺疾病(COPD)的成年人(n = 42)随机分为两组,一组接受为期4周、共8节课程的干预(CALM呼吸法,n = 20),另一组接受常规护理(n = 22)。CALM呼吸法干预包括量身定制的缓慢鼻腔呼吸练习、二氧化碳描记生物反馈、动机性访谈以及家庭呼吸练习计划。该干预旨在消除功能失调的呼吸行为。在研究的第二阶段,所有参与者都获得了门诊肺康复(PR)服务。主要结局指标为CALM呼吸法的可行性及可接受性。探索性次要结局指标包括呼吸和情绪症状、生理及运动耐量指标、生活质量以及肺康复的参与情况。
CALM呼吸法课程的出勤率为84%,退出率为5%,根据纸质记录和设备记录,家庭练习的完成率分别为90%和73%。92%的参与者对CALM呼吸法治疗的满意度评为“良好”至“优秀”。与常规护理相比,干预后6周时,支持CALM呼吸法的次要结局指标——呼吸症状、活动回避、血氧饱和度(SpO₂)、呼气末二氧化碳分压以及呼吸自我调节(内感受)在组间有显著更大改善。在3个月时(肺康复开始后),6分钟步行试验后在Borg呼吸困难评分和SpO₂方面组间有统计学显著差异,也支持CALM呼吸法。
以患者为中心的CALM呼吸法在患有COPD及呼吸困难焦虑症的成年人中可行且可接受。CALM呼吸法干预可能优化呼吸困难治疗并补充肺康复治疗。